Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Oct 20;2(9):100670. doi: 10.1016/j.jacadv.2023.100670

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Safety and Efficacy of Pharmacomechanical Catheter-Directed Thrombolysis With Bashir Endovascular Catheter (Core Laboratory Data)

(A) Reduction in right ventricular/left ventricular (RV/LV) ratio across various acute PE trials.⁶^,⁷^,9, 10, 11, 12^,16, 17, 18 (B) Percent reduction in pulmonary artery obstruction across various contemporary CDT trials.⁶^,⁷^,9, 10, 11, 12^,¹⁸^,¹⁹ (C) Percent reduction in pulmonary artery obstruction per mg of t-PA in contemporary catheter-directed thrombolysis trials.⁶^,⁷^,⁹^,¹²^,¹⁸ (D) Major bleeding rates in intermediate risk PE trials.9, 10, 11, 12^,¹⁶^,¹⁸ CDT = catheter-directed thrombolysis; PE = pulmonary embolism.